Travere Therapeutics (TVTX) News Today $17.50 -0.20 (-1.13%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$17.52 +0.02 (+0.11%) As of 08/29/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TVTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Driehaus Capital Management LLC Acquires 549,718 Shares of Travere Therapeutics, Inc. $TVTX3 hours ago | marketbeat.comWalleye Capital LLC Sells 158,092 Shares of Travere Therapeutics, Inc. $TVTXAugust 29 at 5:20 AM | marketbeat.comTravere Therapeutics stock jumps after FDA approves reduced monitoring for FILSPARIAugust 28 at 1:25 PM | au.investing.comTravere Therapeutics Announces U.S. FDA Approves REMS Modification for FILSPARI® (sparsentan) in IgA NephropathyAugust 27, 2025 | businesswire.comInvesco Ltd. Lowers Position in Travere Therapeutics, Inc. $TVTXAugust 27, 2025 | marketbeat.com21,094 Shares in Travere Therapeutics, Inc. $TVTX Acquired by Penn Capital Management Company LLCAugust 26, 2025 | marketbeat.comWall Street Zen Downgrades Travere Therapeutics (NASDAQ:TVTX) to HoldAugust 26, 2025 | marketbeat.comTravere Therapeutics, Inc. $TVTX Shares Purchased by Charles Schwab Investment Management Inc.August 26, 2025 | marketbeat.comCanaccord Genuity Sticks to Its Buy Rating for Travere Therapeutics (TVTX)August 25, 2025 | theglobeandmail.comVanguard Group Inc. Reduces Stock Position in Travere Therapeutics, Inc. $TVTXAugust 25, 2025 | marketbeat.comTravere Therapeutics (NASDAQ:TVTX) Cut to "Hold" at Wall Street ZenAugust 25, 2025 | americanbankingnews.comCandriam S.C.A. Takes Position in Travere Therapeutics, Inc. $TVTXAugust 24, 2025 | marketbeat.comTravere Therapeutics Earnings Call Highlights FILSPARI SuccessAugust 23, 2025 | theglobeandmail.comAberdeen Group plc Raises Stock Holdings in Travere Therapeutics, Inc. $TVTXAugust 22, 2025 | marketbeat.comNuveen LLC Makes New Investment in Travere Therapeutics, Inc. $TVTXAugust 20, 2025 | marketbeat.comCiti Lifts Travere Therapeutics (TVTX) PT to $34 on Strong Q2 and Upcoming FDA CatalystsAugust 18, 2025 | msn.comWall Street Zen Upgrades Travere Therapeutics (NASDAQ:TVTX) to BuyAugust 17, 2025 | marketbeat.comInformed Momentum Co LLC Invests $2.69 Million in Travere Therapeutics, Inc. (NASDAQ:TVTX)August 14, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX)August 13, 2025 | marketbeat.comTravere Therapeutics, Inc. (NASDAQ:TVTX) Given Consensus Rating of "Moderate Buy" by AnalystsAugust 12, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Outlook for TVTX EarningsAugust 11, 2025 | marketbeat.comTravere Therapeutics price target raised to $32 from $30 at WedbushAugust 8, 2025 | finance.yahoo.comTravere Therapeutics (NASDAQ:TVTX) Given New $31.00 Price Target at ScotiabankAugust 8, 2025 | marketbeat.comWedbush Boosts Travere Therapeutics (NASDAQ:TVTX) Price Target to $32.00August 8, 2025 | marketbeat.comTravere Therapeutics shares rise as Q2 results top expectationsAugust 7, 2025 | investing.comTravere Therapeutics Reports Strong Q2 2025 GrowthAugust 7, 2025 | msn.comTravere Therapeutics, Inc. (TVTX) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comTravere Therapeutics, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comEarnings Preview: Travere TherapeuticsAugust 5, 2025 | benzinga.comXTX Topco Ltd Has $935,000 Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)August 4, 2025 | marketbeat.comTravere Therapeutics, Inc. (NASDAQ:TVTX) Short Interest UpdateAugust 2, 2025 | marketbeat.comTravere Therapeutics (TVTX) Expected to Announce Earnings on ThursdayJuly 31, 2025 | marketbeat.comTravere Therapeutics to Report Second Quarter 2025 Financial ResultsJuly 30, 2025 | businesswire.comEssex Investment Management Co. LLC Makes New Investment in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 29, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Has $6.07 Million Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 28, 2025 | marketbeat.com32,731 Shares in Travere Therapeutics, Inc. (NASDAQ:TVTX) Acquired by Legato Capital Management LLCJuly 26, 2025 | marketbeat.comBank of New York Mellon Corp Boosts Stake in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 26, 2025 | marketbeat.comJennison Associates LLC Increases Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 21, 2025 | marketbeat.comWedbush Forecasts Reduced Earnings for Travere TherapeuticsJuly 17, 2025 | marketbeat.comWedbush Expects Lower Earnings for Travere TherapeuticsJuly 16, 2025 | marketbeat.comEmerald Advisers LLC Lowers Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 13, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Increases Stock Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 12, 2025 | marketbeat.comTravere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 11, 2025 | businesswire.com109,542 Shares in Travere Therapeutics, Inc. (NASDAQ:TVTX) Purchased by Penserra Capital Management LLCJuly 8, 2025 | marketbeat.comLeerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX)July 6, 2025 | insidermonkey.comLeerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX)July 6, 2025 | msn.comInsider Selling: Travere Therapeutics, Inc. (NASDAQ:TVTX) Insider Sells 815 Shares of StockJuly 3, 2025 | insidertrades.comQ2 EPS Estimate for Travere Therapeutics Cut by AnalystJuly 3, 2025 | marketbeat.comJula Inrig Sells 815 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) StockJuly 2, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTXJuly 2, 2025 | prnewswire.com Get Travere Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TVTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TVTX Media Mentions By Week TVTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVTX News Sentiment▼1.021.09▲Average Medical News Sentiment TVTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVTX Articles This Week▼167▲TVTX Articles Average Week Get the Latest News and Ratings for TVTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Regencell Bioscience News Today Avidity Biosciences News Today Axsome Therapeutics News Today Abivax News Today Nuvalent News Today Merus News Today CRISPR Therapeutics News Today TG Therapeutics News Today Cytokinetics News Today Ascentage Pharma Group International News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVTX) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVTX Stock Alerts